(20R)-Ginsenoside Rh2 (BioDeep_00000000011)

 

Secondary id: BioDeep_00000019022, BioDeep_00000622797, BioDeep_00000796591

PANOMIX_OTCML-2023


代谢物信息卡片


3-O-β-D-Glucopyranosyl-20(S)-protopanaxadiol

化学式: C36H62O8 (622.4444)
中文名称: (S型)人参皂苷Rh2, 人参皂苷 R-Rh2, 20(R)-人参皂甙, 人参皂苷 Rh2, 20(S)-人参皂苷CK, 20(S)-人参皂苷 C-K, 20(R)-人参皂苷 RH2, 20(S)-人参皂苷Rh2, 20(R)-人参皂苷Rh2, 人参皂苷CK
谱图信息: 最多检出来源 Viridiplantae(plant) 12.11%

Reviewed

Last reviewed on 2024-07-12.

Cite this Page

(20R)-Ginsenoside Rh2. BioDeep Database v3. PANOMIX ltd, a top metabolomics service provider from China. https://query.biodeep.cn/s/(20r)-ginsenoside_rh2 (retrieved 2024-12-22) (BioDeep RN: BioDeep_00000000011). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

分子结构信息

SMILES: C1C[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)C(C)(C)[C@]2([H])CC[C@@]3(C)[C@]4(C)CC[C@@]([C@](O)(C)CC/C=C(\C)/C)([H])[C@@]4([H])[C@H](O)C[C@]3([H])[C@@]12C
InChI: InChI=1S/C36H62O8/c1-20(2)10-9-14-36(8,42)21-11-16-35(7)27(21)22(38)18-25-33(5)15-13-26(32(3,4)24(33)12-17-34(25,35)6)44-31-30(41)29(40)28(39)23(19-37)43-31/h10,21-31,37-42H,9,11-19H2,1-8H3/t21-,22+,23+,24-,25+,26-,27-,28+,29-,30+,31-,33-,34+,35+,36-/m0/s1

描述信息

(20S)-ginsenoside Rh2 is a ginsenoside found in Panax species that is dammarane which is substituted by hydroxy groups at the 3beta, 12beta and 20 pro-S positions, in which the hydroxy group at position 3 has been converted to the corresponding beta-D-glucopyranoside, and in which a double bond has been introduced at the 24-25 position. It has a role as a plant metabolite, an antineoplastic agent, an apoptosis inducer, a cardioprotective agent, a bone density conservation agent and a hepatoprotective agent. It is a beta-D-glucoside, a 12beta-hydroxy steroid, a ginsenoside, a tetracyclic triterpenoid and a 20-hydroxy steroid. It derives from a hydride of a dammarane.
Ginsenoside Rh2 is a natural product found in Panax ginseng and Panax notoginseng with data available.
A ginsenoside found in Panax species that is dammarane which is substituted by hydroxy groups at the 3beta, 12beta and 20 pro-S positions, in which the hydroxy group at position 3 has been converted to the corresponding beta-D-glucopyranoside, and in which a double bond has been introduced at the 24-25 position.
Ginsenoside C-K, a bacterial metabolite of G-Rb1, exhibits anti-inflammatory effects by reducing iNOS and COX-2. Ginsenoside C-K exhibits an inhibition against the activity of CYP2C9 and CYP2A6 in human liver microsomes with IC50s of 32.0±3.6 μM and 63.6±4.2 μM, respectively.
Ginsenoside C-K, a bacterial metabolite of G-Rb1, exhibits anti-inflammatory effects by reducing iNOS and COX-2. Ginsenoside C-K exhibits an inhibition against the activity of CYP2C9 and CYP2A6 in human liver microsomes with IC50s of 32.0±3.6 μM and 63.6±4.2 μM, respectively.
Ginsenoside Rh2 induces the activation of caspase-8 and caspase-9. Ginsenoside Rh2 induces cancer cell apoptosis in a multi-path manner.
Ginsenoside Rh2 induces the activation of caspase-8 and caspase-9. Ginsenoside Rh2 induces cancer cell apoptosis in a multi-path manner.

同义名列表

34 个代谢物同义名

(2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol; .BETA.-D-GLUCOPYRANOSIDE, (3.BETA.,12.BETA.)-12,20-DIHYDROXYDAMMAR-24-EN-3-YL; beta-D-Glucopyranoside, (3beta,12beta)-12,20-dihydroxydammar-24-en-3-yl; (3beta,12beta)-12,20-dihydroxydammar-24-en-3-yl beta-D-glucopyranoside; (S)-(3b,12b)-12,20-Dihydroxydammar-24-en-3-yl beta-D-glucopyranoside; 12beta,20-dihydroxydammar-24-en-3beta-yl beta-D-glucopyranoside; 3beta-(beta-D-glucopyranosyloxy)dammar-24-ene-3beta,20beta-diol; 3-O-.BETA.-D-GLUCOPYRANOSYL-20(S)-PROTOPANAXADIOL; 20S-protopanaxdiol-3-O-beta-D- glucopyranoside; Ginsenoside Rh2; Ginsenoside Rh2, analytical standard; 20-(R)-Ginsenoside Rh2; 20(S)- Ginsenoside Rh2; 20(S)-Ginsenoside Rh2; 20(R)-Ginsenoside Rh2; (20R)-Ginsenoside Rh2; (20S)-ginsenoside Rh2; (20R)Ginsenoside Rh2; 20S-Ginsenoside Rh2; GINSENOSIDE RH2(S); 20S-GinsenosideRh2; GINSENOSIDE 20-RH2; 20(S)-Ginsenoside; 20(R)-Ginsenoside; ginsenoside C-K; Ginsenoside Rh2; ginsenoside-Rh2; UNII-0JU44A5KWG; GinsenosideRh2; 0JU44A5KWG; 20(S)-Rh2; Ginsenoside K; 20(s)-Ginsenoside Rh2; Ginsenoside compound K



数据库引用编号

20 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(2)

PlantCyc(1)

代谢反应

4 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(2)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(2)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

53 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。

亚细胞结构定位 关联基因列表
Cytoplasm 13 AKT1, BCL2, CASP1, CASP9, CDK2, CDK4, CDKN1A, CDKN2A, MTOR, PIK3CA, PRKAA2, PTGS2, RB1
Peripheral membrane protein 2 MTOR, PTGS2
Endoplasmic reticulum membrane 3 BCL2, MTOR, PTGS2
Nucleus 12 AKT1, BCL2, CASP9, CDK2, CDK4, CDKN1A, CDKN2A, MTOR, PARP1, PRKAA2, RB1, RBL2
autophagosome 1 MAP1LC3A
cytosol 15 AKT1, BCL2, CASP1, CASP9, CDK2, CDK4, CDKN1A, CDKN2A, MAP1LC3A, MTOR, PARP1, PIK3CA, PRKAA2, RB1, RBL2
dendrite 2 MTOR, PRKAA2
nuclear body 2 CDKN1A, PARP1
phagocytic vesicle 1 MTOR
centrosome 1 CDK2
nucleoplasm 10 AKT1, CDK2, CDK4, CDKN1A, CDKN2A, MTOR, PARP1, PRKAA2, RB1, RBL2
Cell membrane 3 AKT1, CASP1, TNF
Lipid-anchor 1 MAP1LC3A
Cytoplasmic side 1 MTOR
lamellipodium 2 AKT1, PIK3CA
Golgi apparatus membrane 1 MTOR
cell cortex 1 AKT1
cell surface 1 TNF
glutamatergic synapse 2 AKT1, MAP1LC3A
Golgi apparatus 1 PRKAA2
Golgi membrane 2 INS, MTOR
lysosomal membrane 1 MTOR
neuronal cell body 2 PRKAA2, TNF
postsynapse 1 AKT1
Cytoplasm, cytosol 1 PARP1
Lysosome 1 MTOR
endosome 1 CDK2
plasma membrane 5 AKT1, CASP1, IFNLR1, PIK3CA, TNF
Membrane 6 AKT1, BCL2, IFNLR1, MTOR, PARP1, PRKAA2
axon 1 PRKAA2
caveola 1 PTGS2
extracellular exosome 1 RBL2
Lysosome membrane 1 MTOR
endoplasmic reticulum 2 BCL2, PTGS2
extracellular space 3 IL6, INS, TNF
perinuclear region of cytoplasm 2 CDKN1A, PIK3CA
bicellular tight junction 1 CDK4
intercalated disc 1 PIK3CA
mitochondrion 4 BCL2, CASP9, CDKN2A, PARP1
protein-containing complex 8 AKT1, BCL2, CASP1, CASP9, CDKN1A, CDKN2A, PARP1, PTGS2
intracellular membrane-bounded organelle 1 MAP1LC3A
Microsome membrane 2 MTOR, PTGS2
TORC1 complex 1 MTOR
TORC2 complex 1 MTOR
Single-pass type I membrane protein 1 IFNLR1
Secreted 2 IL6, INS
extracellular region 3 IL6, INS, TNF
Mitochondrion outer membrane 2 BCL2, MTOR
Single-pass membrane protein 1 BCL2
mitochondrial outer membrane 2 BCL2, MTOR
mitochondrial matrix 1 CDKN2A
transcription regulator complex 4 CDK2, CDK4, PARP1, RBL2
Cytoplasm, cytoskeleton, microtubule organizing center, centrosome 1 CDK2
Nucleus membrane 2 BCL2, CDK4
Bcl-2 family protein complex 1 BCL2
nuclear membrane 2 BCL2, CDK4
external side of plasma membrane 1 TNF
microtubule cytoskeleton 1 AKT1
nucleolus 6 CASP1, CDK4, CDKN1A, CDKN2A, PARP1, RBL2
cell-cell junction 1 AKT1
recycling endosome 1 TNF
Single-pass type II membrane protein 1 TNF
vesicle 1 AKT1
Membrane raft 1 TNF
pore complex 1 BCL2
Cytoplasm, cytoskeleton 1 MAP1LC3A
microtubule 2 CASP1, MAP1LC3A
spindle 2 AKT1, RB1
Nucleus, PML body 1 MTOR
PML body 2 MTOR, RB1
Mitochondrion intermembrane space 1 AKT1
mitochondrial intermembrane space 1 AKT1
nuclear speck 1 PRKAA2
NLRP3 inflammasome complex 1 CASP1
Nucleus inner membrane 1 PTGS2
Nucleus outer membrane 1 PTGS2
nuclear inner membrane 1 PTGS2
nuclear outer membrane 1 PTGS2
Late endosome 1 MAP1LC3A
neuron projection 1 PTGS2
ciliary basal body 1 AKT1
chromatin 4 CDK4, PARP1, RB1, RBL2
Cytoplasmic vesicle, autophagosome membrane 1 MAP1LC3A
autophagosome membrane 1 MAP1LC3A
phagocytic cup 1 TNF
Chromosome 2 PARP1, RBL2
Nucleus, nucleolus 2 CDKN2A, PARP1
nuclear replication fork 1 PARP1
chromosome, telomeric region 2 CDK2, PARP1
organelle membrane 1 MAP1LC3A
site of double-strand break 1 PARP1
nuclear envelope 3 CDK2, MTOR, PARP1
Endomembrane system 2 MAP1LC3A, MTOR
endosome lumen 1 INS
Nucleus, nucleoplasm 1 CDKN2A
cytoplasmic stress granule 1 PRKAA2
myelin sheath 1 BCL2
secretory granule lumen 1 INS
Golgi lumen 1 INS
endoplasmic reticulum lumen 3 IL6, INS, PTGS2
male germ cell nucleus 1 CDK2
phosphatidylinositol 3-kinase complex 1 PIK3CA
phosphatidylinositol 3-kinase complex, class IA 1 PIK3CA
transport vesicle 1 INS
Endoplasmic reticulum-Golgi intermediate compartment membrane 1 INS
SWI/SNF complex 1 RB1
apoptosome 1 CASP9
AIM2 inflammasome complex 1 CASP1
Cajal body 1 CDK2
protein-DNA complex 1 PARP1
canonical inflammasome complex 1 CASP1
nucleotide-activated protein kinase complex 1 PRKAA2
condensed chromosome 1 CDK2
Cytoplasmic vesicle, phagosome 1 MTOR
Nucleus, Cajal body 1 CDK2
X chromosome 1 CDK2
Y chromosome 1 CDK2
site of DNA damage 1 PARP1
cyclin-dependent protein kinase holoenzyme complex 3 CDK2, CDK4, CDKN1A
cyclin E1-CDK2 complex 1 CDK2
cyclin E2-CDK2 complex 1 CDK2
[Tumor necrosis factor, soluble form]: Secreted 1 TNF
Autolysosome 1 MAP1LC3A
interleukin-6 receptor complex 1 IL6
chromatin lock complex 1 RB1
Rb-E2F complex 1 RB1
[Poly [ADP-ribose] polymerase 1, processed N-terminus]: Chromosome 1 PARP1
[Poly [ADP-ribose] polymerase 1, processed C-terminus]: Cytoplasm 1 PARP1
BAD-BCL-2 complex 1 BCL2
cyclin D1-CDK4 complex 1 CDK4
cyclin D2-CDK4 complex 1 CDK4
cyclin D3-CDK4 complex 1 CDK4
PCNA-p21 complex 1 CDKN1A
senescence-associated heterochromatin focus 1 CDKN2A
cyclin A2-CDK2 complex 1 CDK2
cyclin A1-CDK2 complex 1 CDK2
IPAF inflammasome complex 1 CASP1
NLRP1 inflammasome complex 1 CASP1
protease inhibitor complex 1 CASP1
phosphatidylinositol 3-kinase complex, class IB 1 PIK3CA
caspase complex 1 CASP9
interleukin-28 receptor complex 1 IFNLR1
[C-domain 2]: Secreted 1 TNF
[Tumor necrosis factor, membrane form]: Membrane 1 TNF
[C-domain 1]: Secreted 1 TNF
[Isoform smARF]: Mitochondrion 1 CDKN2A


文献列表

  • Hui Ao, Huizhu Song, Jing Li, Xiangtao Wang. Enhanced anti-glioma activity of annonaceous acetogenins based on a novel liposomal co-delivery system with ginsenoside Rh2. Drug delivery. 2024 Dec; 31(1):2324716. doi: 10.1080/10717544.2024.2324716. [PMID: 38555735]
  • Xiyu Liu, Jingjing Li, Qingqing Huang, Mingming Jin, Gang Huang. Ginsenoside Rh2 shifts tumor metabolism from aerobic glycolysis to oxidative phosphorylation through regulating the HIF1-α/PDK4 axis in non-small cell lung cancer. Molecular medicine (Cambridge, Mass.). 2024 Apr; 30(1):56. doi: 10.1186/s10020-024-00813-y. [PMID: 38671369]
  • Jiaxin Chen, Zhuoshi Wang, Jinghao Fu, Yuesong Cai, Haoyi Cheng, Xinmu Cui, Manqing Sun, Mingyue Liu, Xuewu Zhang. Ginsenoside compound K induces ferroptosis via the FOXO pathway in liver cancer cells. BMC complementary medicine and therapies. 2024 Apr; 24(1):174. doi: 10.1186/s12906-024-04471-9. [PMID: 38664638]
  • Subecha Rai, Laishram Shantikumar Singh, Ramanan Uma Shaanker, Kumaraswamy Jeyaram, Tithi Parija, Dinabandhu Sahoo. Endophytic fungi of Panax sokpayensis produce bioactive ginsenoside Compound K in flask fermentation. Scientific reports. 2024 04; 14(1):9318. doi: 10.1038/s41598-024-56441-3. [PMID: 38654024]
  • Md Niaj Morshed, Md Rezaul Karim, Reshmi Akter, Safia Iqbal, Ramya Mathiyalagan, Jong Chan Ahn, Deok Chun Yang, Joong Hyun Song, Se Chan Kang, Dong Uk Yang. Potential of Gut Microbial Metabolites in Treating Osteoporosis and Obesity: A Network Pharmacology and Bioinformatics Approach. Medical science monitor : international medical journal of experimental and clinical research. 2024 Mar; 30(?):e942899. doi: 10.12659/msm.942899. [PMID: 38509819]
  • Kang-Xi Zhang, Yue Zhu, Shu-Xia Song, Qing-Yun Bu, Xiao-Yan You, Hong Zou, Guo-Ping Zhao. Ginsenoside Rb1, Compound K and 20(S)-Protopanaxadiol Attenuate High-Fat Diet-Induced Hyperlipidemia in Rats via Modulation of Gut Microbiota and Bile Acid Metabolism. Molecules (Basel, Switzerland). 2024 Mar; 29(5):. doi: 10.3390/molecules29051108. [PMID: 38474620]
  • Juho Lim, Hayeong Kim, Gha-Hyun J Kim, Taeyoon Kim, Choon Gil Kang, Seung Wook Kim, Doman Kim. Enzymatic upcycling of wild-simulated ginseng leaves for enhancing biological activities and compound K. Applied microbiology and biotechnology. 2024 Feb; 108(1):207. doi: 10.1007/s00253-024-13028-2. [PMID: 38353757]
  • Hoon Kim, Eun-Jin Jeong, Byungdoo Hwang, Hak-Dong Lee, Sanghyun Lee, Mi Jang, Kwangeun Yeo, Yunjeong Shin, Sanghoon Park, Wan Taek Lim, Woo Jung Kim, Sung-Kwon Moon. Pharmacological effects of biologically synthesized ginsenoside CK-rich preparation (AceCK40) on the colitis symptoms in DSS-induced Caco-2 cells and C57BL mice. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2024 Feb; 124(?):155301. doi: 10.1016/j.phymed.2023.155301. [PMID: 38181531]
  • Lan Yang, Jenny Jie Chen, Brian Sheng-Xian Teo, Jiong Zhang, Mingqiang Jiang. Research Progress on the Antitumor Molecular Mechanism of Ginsenoside Rh2. The American journal of Chinese medicine. 2024 Jan; ?(?):1-14. doi: 10.1142/s0192415x24500095. [PMID: 38291582]
  • Jieyu Long, Wanshan Hu, Tao Ren, Xuewen Wang, Chao Lu, Xin Pan, Chuanbin Wu, Tingting Peng. Combating multidrug resistance of breast cancer with ginsenoside Rh2-irrigated nano-in-thermogel. International journal of pharmaceutics. 2024 Jan; 650(?):123718. doi: 10.1016/j.ijpharm.2023.123718. [PMID: 38104849]
  • Hyun Ho Shin, Junyoung Park, Yeo-Jin Kim, Donghyeon Kim, Eun-Jung Jin, Ji Hyun Ryu. Hydrophilic/Hydrophobic Janus Nanofibers Containing Compound K for Cartilage Regeneration. International journal of nanomedicine. 2024; 19(?):1683-1697. doi: 10.2147/ijn.s435156. [PMID: 38445226]
  • Chunmei Yang, Cheng Qian, Weiwei Zheng, Guanglu Dong, Shan Zhang, Feihui Wang, Zhonghong Wei, Yuhua Xu, Aiyun Wang, Yang Zhao, Yin Lu. Ginsenoside Rh2 enhances immune surveillance of natural killer (NK) cells via inhibition of ERp5 in breast cancer. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2024 Jan; 123(?):155180. doi: 10.1016/j.phymed.2023.155180. [PMID: 38043385]
  • Chao Hong, Anni Wang, Jiaxuan Xia, Jianming Liang, Ying Zhu, Dan Wang, Huaxing Zhan, Chunbo Feng, Xinnan Jiang, Junjie Pan, Jianxin Wang. Ginsenoside Rh2-Based Multifunctional Liposomes for Advanced Breast Cancer Therapy. International journal of nanomedicine. 2024; 19(?):2879-2888. doi: 10.2147/ijn.s437733. [PMID: 38525007]
  • Mu-Yang Huang, Yu-Chi Chen, Wen-Yu Lyu, Xin-Yu He, Zi-Han Ye, Can-Yu Huang, Xin-Ling He, Xiuping Chen, Xiaobing Chen, Baoxian Zhang, Guoyin Kai, Xiaolei Zhang, Ting Li, Mingqing Huang, Jin-Jian Lu. Ginsenoside Rh2 augmented anti-PD-L1 immunotherapy by reinvigorating CD8+ T cells via increasing intratumoral CXCL10. Pharmacological research. 2023 Dec; 198(?):106988. doi: 10.1016/j.phrs.2023.106988. [PMID: 37984507]
  • Tianyang Zhao. Suppression or Inhibition of VEGFs on Splenic Angiosarcoma Cell with Traditional Chinese Medicine Zhi Gan Cao. Studies in health technology and informatics. 2023 Nov; 308(?):396-403. doi: 10.3233/shti230865. [PMID: 38007765]
  • Wenfeng Shen, Paul A Dalby, Zheng Guo, Weina Li, Chenhui Zhu, Daidi Fan. Residue Effect-Guided Design: Engineering of S. Solfataricus β-Glycosidase to Enhance Its Thermostability and Bioproduction of Ginsenoside Compound K. Journal of agricultural and food chemistry. 2023 Oct; ?(?):. doi: 10.1021/acs.jafc.3c04575. [PMID: 37812684]
  • Chunyan Yue, Dandan Li, Shuxin Fan, Feng Tao, Yue Yu, Wenjing Lu, Qian Chen, Ahu Yuan, Jinhui Wu, Guoping Zhao, Hong Dong, Yiqiao Hu. Long-term and liver-selected ginsenoside C-K nanoparticles retard NAFLD progression by restoring lipid homeostasis. Biomaterials. 2023 Aug; 301(?):122291. doi: 10.1016/j.biomaterials.2023.122291. [PMID: 37619263]
  • Yahui Hu, Shasha He, Xiaolong Xu, Xuran Cui, Yiming Wei, Chunxia Zhao, Haoran Ye, Jingxia Zhao, Qingquan Liu. Shenhuangdan decoction alleviates sepsis-induced lung injury through inhibition of GSDMD-mediated pyroptosis. Journal of ethnopharmacology. 2023 Aug; 318(Pt B):117047. doi: 10.1016/j.jep.2023.117047. [PMID: 37586442]
  • Chuanjing Cheng, Jinling Zhang, Kaixin Liu, Yanyan Xu, Fukui Shen, Yanqi Han, Yuanyuan Hou, Tiejun Zhang, Gang Bai. Ginsenoside CK targeting KEAP1-DGR/Kelch domain disrupts the binding between KEAP1 and NRF2-DLG motif to ameliorate oxidative stress damage. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2023 Jul; 119(?):154992. doi: 10.1016/j.phymed.2023.154992. [PMID: 37499433]
  • Wei Guan, Wang Qi. Ginsenoside Rh2: A shining and potential natural product in the treatment of human nonmalignant and malignant diseases in the near future. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2023 Jun; 118(?):154938. doi: 10.1016/j.phymed.2023.154938. [PMID: 37406390]
  • Feng Li, Meng Meng Chen, Hui Min Zhang, Qing Ping Wu, Yun Bin Han. Production of ginsenoside compound K by microbial cell factory using synthetic biology-based strategy: a review. Biotechnology letters. 2023 Feb; 45(2):163-174. doi: 10.1007/s10529-022-03326-y. [PMID: 36550334]
  • Dong Zhang, Siwei Duan, Zhangyou He, Zeming Zhu, Zhiping Li, Qincheng Yi, Tiantian Cai, Juanjuan Li, Nan Chen, Shaoju Guo. Sijunzi Decoction Targets IL1B and TNF to Reduce Neutrophil Extracellular Traps (NETs) in Ulcerative Colitis: Evidence from Silicon Prediction and Experiment Validation. Drug design, development and therapy. 2023; 17(?):3103-3128. doi: 10.2147/dddt.s428814. [PMID: 37868820]
  • Ji-Hyeon Jeon, Jin-Hyang Park, So Yeon Jeon, Minyeong Pang, Min-Koo Choi, Im-Sook Song. Concomitant Administration of Red Ginseng Extract with Lactic Acid Bacteria Increases the Plasma Concentration of Deglycosylated Ginsenosides in Healthy Human Subjects. Biomolecules. 2022 12; 12(12):. doi: 10.3390/biom12121896. [PMID: 36551324]
  • Ying Liu, Xinran Wang, Juhui Qiao, Jiawen Wang, Leilei Jiang, Chenxi Wang, Shiting Yu, Peiguang Zhang, Daqing Zhao, Meiling Fan, Meichen Liu. Ginsenoside Rh2 Induces HeLa Apoptosis through Upregulating Endoplasmic Reticulum Stress-Related and Downstream Apoptotic Gene Expression. Molecules (Basel, Switzerland). 2022 Nov; 27(22):. doi: 10.3390/molecules27227865. [PMID: 36431966]
  • Qian Chen, Dongwen Ren, Luokun Liu, Jingge Xu, Yuzheng Wu, Haiyang Yu, Mengyang Liu, Yi Zhang, Tao Wang. Ginsenoside Compound K Ameliorates Development of Diabetic Kidney Disease through Inhibiting TLR4 Activation Induced by Microbially Produced Imidazole Propionate. International journal of molecular sciences. 2022 Oct; 23(21):. doi: 10.3390/ijms232112863. [PMID: 36361652]
  • Jingjing Zhang, Yangliu Tong, Xun Lu, Fangming Dong, Xiaoxuan Ma, Shiyu Yin, Ying He, Yonghong Liu, Qingchao Liu, Daidi Fan. A derivant of ginsenoside CK and its inhibitory effect on hepatocellular carcinoma. Life sciences. 2022 Sep; 304(?):120698. doi: 10.1016/j.lfs.2022.120698. [PMID: 35690105]
  • Darcy Lacanilao Garza, Shinya Hanashima, Yuichi Umegawa, Michio Murata, Masanao Kinoshita, Nobuaki Matsumori, Peter Greimel. Behavior of Triterpenoid Saponin Ginsenoside Rh2 in Ordered and Disordered Phases in Model Membranes Consisting of Sphingomyelin, Phosphatidylcholine, and Cholesterol. Langmuir : the ACS journal of surfaces and colloids. 2022 08; 38(34):10478-10491. doi: 10.1021/acs.langmuir.2c01261. [PMID: 35984899]
  • Woo-Seok Song, Min-Ju Kim, Kyung-Chul Shin, Deok-Kun Oh. Increased Production of Ginsenoside Compound K by Optimizing the Feeding of American Ginseng Extract during Fermentation by Aspergillus tubingensis. Journal of microbiology and biotechnology. 2022 Jul; 32(7):902-910. doi: 10.4014/jmb.2203.03059. [PMID: 35719083]
  • Siyu Chen, Ziwei He, Wei Xie, Xuan Chen, Zhuofeng Lin, Jisheng Ma, Zhi Liu, Shihai Yang, Yanfang Wang. Ginsenoside Rh2 attenuates CDAHFD-induced liver fibrosis in mice by improving intestinal microbial composition and regulating LPS-mediated autophagy. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2022 Jul; 101(?):154121. doi: 10.1016/j.phymed.2022.154121. [PMID: 35489327]
  • Jie Xu, Jinxiang Dong, Hongyue Ding, Bei Wang, Yuqi Wang, Zhidong Qiu, Fan Yao. Ginsenoside compound K inhibits obesity-induced insulin resistance by regulation of macrophage recruitment and polarization via activating PPARγ. Food & function. 2022 Mar; 13(6):3561-3571. doi: 10.1039/d1fo04273d. [PMID: 35260867]
  • Jingjing Zhang, Xiaoxuan Ma, Daidi Fan. Ginsenoside CK ameliorates hepatic lipid accumulation via activating the LKB1/AMPK pathway in vitro and in vivo. Food & function. 2022 Feb; 13(3):1153-1167. doi: 10.1039/d1fo03026d. [PMID: 35018944]
  • Li Yang, Lingjie Zheng, Xiaonv Xie, Junjia Luo, Jing Yu, Lihua Zhang, Wenhui Meng, Yingen Zhou, Ling Chen, Dongsheng Ouyang, Honghao Zhou, Zhirong Tan. Targeting PLA2G16, a lipid metabolism gene, by Ginsenoside Compound K to suppress the malignant progression of colorectal cancer. Journal of advanced research. 2022 02; 36(?):265-276. doi: 10.1016/j.jare.2021.06.009. [PMID: 35127176]
  • Zhongwen Qi, Zhipeng Yan, Yueyao Wang, Nan Ji, Xiaoya Yang, Ao Zhang, Meng Li, Fengqin Xu, Junping Zhang. Ginsenoside Rh2 Inhibits NLRP3 Inflammasome Activation and Improves Exosomes to Alleviate Hypoxia-Induced Myocardial Injury. Frontiers in immunology. 2022; 13(?):883946. doi: 10.3389/fimmu.2022.883946. [PMID: 35865525]
  • Xin-Ling He, Xiao-Huang Xu, Jia-Jie Shi, Mingqing Huang, Yitao Wang, Xiuping Chen, Jin-Jian Lu. Anticancer Effects of Ginsenoside Rh2: A Systematic Review. Current molecular pharmacology. 2022; 15(1):179-189. doi: 10.2174/1874467214666210309115105. [PMID: 33687905]
  • Mu Seong Ban, Yun Kim, Sunyoung Lee, ByongYeul Han, Kyung-Sang Yu, In-Jin Jang, Hong Keun Chung, SeungHwan Lee. Pharmacokinetics of Ginsenoside Compound K From a Compound K Fermentation Product, CK-30, and From Red Ginseng Extract in Healthy Korean Subjects. Clinical pharmacology in drug development. 2021 11; 10(11):1358-1364. doi: 10.1002/cpdd.949. [PMID: 33884767]
  • Su-Nyeong Jang, So-Young Park, Hyunyoung Lee, Hyojin Jeong, Ji-Hyeon Jeon, Im-Sook Song, Mi Jeong Kwon, Kwang-Hyeon Liu. In vitro modulatory effects of ginsenoside compound K, 20(S)-protopanaxadiol and 20(S)-protopanaxatriol on uridine 5'-diphospho-glucuronosyltransferase activity and expression. Xenobiotica; the fate of foreign compounds in biological systems. 2021 Oct; 51(10):1087-1094. doi: 10.1080/00498254.2021.1963503. [PMID: 34338601]
  • Chenfei Li, Yuan Liang, Yantong Sun, Wencheng Wang, Jie Zhang, Tiehua Zhang. Elucidation of interaction between serum albumin and ginsenoside CK along with cytotoxic study. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. 2021 Sep; 155(?):112403. doi: 10.1016/j.fct.2021.112403. [PMID: 34246707]
  • Suwei Tang, Lingli Yang, Yasutaka Kuroda, Sylvia Lai, Shaoqiong Xie, Huimin Zhang, Ichiro Katayama. Herb Sanqi-Derived Compound K Alleviates Oxidative Stress in Cultured Human Melanocytes and Improves Oxidative-Stress-Related Leukoderma in Guinea Pigs. Cells. 2021 08; 10(8):. doi: 10.3390/cells10082057. [PMID: 34440826]
  • Bei Wang, Jinxiang Dong, Jie Xu, Zhidong Qiu, Fan Yao. Ginsenoside CK inhibits obese insulin resistance by activating PPARγ to interfere with macrophage activation. Microbial pathogenesis. 2021 Aug; 157(?):105002. doi: 10.1016/j.micpath.2021.105002. [PMID: 34051328]
  • Hyuk Gyu Han, Hyo-Jung Lee, Deok Yong Sim, Eunji Im, Ji Eon Park, Woon Yi Park, Seok Young Kim, Jae-Ho Khil, Bum Sang Shim, Sung-Hoon Kim. Suppression of phosphoinositide 3-kinase/phosphoinositide-dependent kinase-1/serum and glucocorticoid-induced protein kinase pathway. Phytotherapy research : PTR. 2021 Aug; 35(8):4547-4554. doi: 10.1002/ptr.7157. [PMID: 34132431]
  • B Shen, F Wang, Y Zhou, T Li, C He, W Zhao. [Ginsenoside Rh2 inhibits renal fibrosis and renal cell apoptosis in rats with diabetic nephropathy by downregulating discoid domain receptor 1]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University. 2021 Jul; 41(7):1107-1113. doi: 10.12122/j.issn.1673-4254.2021.07.21. [PMID: 34308864]
  • In-Hee Baik, Kyung-Hee Kim, Kyung-Ae Lee. Antioxidant, Anti-Inflammatory and Antithrombotic Effects of Ginsenoside Compound K Enriched Extract Derived from Ginseng Sprouts. Molecules (Basel, Switzerland). 2021 Jul; 26(13):. doi: 10.3390/molecules26134102. [PMID: 34279442]
  • Hao Wang, Fangfei Qu, Ting Xin, Wei Sun, Huimin He, Lijun Du. Ginsenoside Compound K Promotes Proliferation, Migration and Differentiation of Schwann Cells via the Activation of MEK/ERK1/2 and PI3K/AKT Pathways. Neurochemical research. 2021 Jun; 46(6):1400-1409. doi: 10.1007/s11064-021-03279-0. [PMID: 33738663]
  • Zhenlei Wang, Rui Liu, Li Chen, Huanhuan Wang, Mi Zhou, Yongsheng Wang, Yongping Qin. Pharmacokinetics of Ginsenoside Rh2, the Major Anticancer Ingredient of Ginsenoside H Dripping Pills, in Healthy Subjects. Clinical pharmacology in drug development. 2021 06; 10(6):669-674. doi: 10.1002/cpdd.877. [PMID: 33021081]
  • Shuqiu Chen, Haihong Ye, Fanger Gong, Suming Mao, Cong Li, Bin Xu, Yu Ren, Rui Yu. Ginsenoside compound K exerts antitumour effects in renal cell carcinoma via regulation of ROS and lncRNA THOR. Oncology reports. 2021 04; 45(4):. doi: 10.3892/or.2021.7989. [PMID: 33649829]
  • Jee Youn Lee, Hae Young Choi, Chan Sol Park, Dong Hyun Kim, Tae Young Yune. Total saponin extract, ginsenoside Rb1, and compound K alleviate peripheral and central neuropathic pain through estrogen receptors on rats. Phytotherapy research : PTR. 2021 Apr; 35(4):2119-2132. doi: 10.1002/ptr.6960. [PMID: 33205558]
  • Jingwei Lv, Cong Lu, Ning Jiang, Haixia Wang, Hong Huang, Ying Chen, Yujiao Li, Xinmin Liu. Protective effect of ginsenoside Rh2 on scopolamine-induced memory deficits through regulation of cholinergic transmission, oxidative stress and the ERK-CREB-BDNF signaling pathway. Phytotherapy research : PTR. 2021 Jan; 35(1):337-345. doi: 10.1002/ptr.6804. [PMID: 32754961]
  • Minghao Sun, Chune Zhu, Jieyu Long, Chao Lu, Xin Pan, Chuanbin Wu. PLGA microsphere-based composite hydrogel for dual delivery of ciprofloxacin and ginsenoside Rh2 to treat Staphylococcus aureus-induced skin infections. Drug delivery. 2020 Dec; 27(1):632-641. doi: 10.1080/10717544.2020.1756985. [PMID: 32329376]
  • Wenxiu Qi, Xiuci Yan, Xiaohao Xu, Bailin Song, Liping Sun, Daqing Zhao, Liwei Sun. The effects of cytarabine combined with ginsenoside compound K synergistically induce DNA damage in acute myeloid leukemia cells. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2020 Dec; 132(?):110812. doi: 10.1016/j.biopha.2020.110812. [PMID: 33059263]
  • Liyan Zhao, Lei Wang, Liping Chang, Yunlong Hou, Cong Wei, Yiling Wu. Ginsenoside CK-loaded self-nanomicellizing solid dispersion with enhanced solubility and oral bioavailability. Pharmaceutical development and technology. 2020 Nov; 25(9):1127-1138. doi: 10.1080/10837450.2020.1800730. [PMID: 32729758]
  • Eun-Bi Jeong, Se-A Kim, Kyung-Chul Shin, Deok-Kun Oh. Biotransformation of Protopanaxadiol-Type Ginsenosides in Korean Ginseng Extract into Food-Available Compound K by an Extracellular Enzyme from Aspergillus niger. Journal of microbiology and biotechnology. 2020 Oct; 30(10):1560-1567. doi: 10.4014/jmb.2007.07003. [PMID: 32807754]
  • Xun Li, Shifeng Chu, Meiyu Lin, Yan Gao, Yingjiao Liu, Songwei Yang, Xin Zhou, Yani Zhang, Yaomei Hu, Huiqin Wang, Naihong Chen. Anticancer property of ginsenoside Rh2 from ginseng. European journal of medicinal chemistry. 2020 Oct; 203(?):112627. doi: 10.1016/j.ejmech.2020.112627. [PMID: 32702586]
  • Dongdong Liu, Siming Jiao, Jinhua Wei, Xuebing Zhang, Yuxin Pei, Zhichao Pei, Jianjun Li, Yuguang Du. Investigation of absorption, metabolism and toxicity of ginsenosides compound K based on human organ chips. International journal of pharmaceutics. 2020 Sep; 587(?):119669. doi: 10.1016/j.ijpharm.2020.119669. [PMID: 32702454]
  • Hongping Lu, Xiaoxue Yuan, Yu Zhang, Ming Han, Shunai Liu, Kai Han, Pu Liang, Jun Cheng. HCBP6 deficiency exacerbates glucose and lipid metabolism disorders in non-alcoholic fatty liver mice. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2020 Sep; 129(?):110347. doi: 10.1016/j.biopha.2020.110347. [PMID: 32535386]
  • Yao Cheng, Ruimei Li, Zixuan Lin, Feiyan Chen, Jianguo Dai, Zhu Zhu, Lin Chen, Yunan Zhao. Structure-activity relationship analysis of dammarane-type natural products as muscle-type creatine kinase activators. Bioorganic & medicinal chemistry letters. 2020 09; 30(17):127364. doi: 10.1016/j.bmcl.2020.127364. [PMID: 32738969]
  • Qingxia Huang, Tingting Lou, Manying Wang, Linyuan Xue, Jing Lu, He Zhang, Zepeng Zhang, Hui Wang, Chenxu Jing, Daqing Zhao, Liwei Sun, Xiangyan Li. Compound K inhibits autophagy-mediated apoptosis induced by oxygen and glucose deprivation/reperfusion via regulating AMPK-mTOR pathway in neurons. Life sciences. 2020 Aug; 254(?):117793. doi: 10.1016/j.lfs.2020.117793. [PMID: 32416164]
  • Chung-Yao Wu, Kuo-Feng Hua, Wan-Han Hsu, Yusuke Suzuki, Lichieh Julie Chu, Yu-Chieh Lee, Akiko Takahata, Sheau-Long Lee, Chia-Chao Wu, David J Nikolic-Paterson, Shuk-Man Ka, Ann Chen. IgA Nephropathy Benefits from Compound K Treatment by Inhibiting NF-κB/NLRP3 Inflammasome and Enhancing Autophagy and SIRT1. Journal of immunology (Baltimore, Md. : 1950). 2020 07; 205(1):202-212. doi: 10.4049/jimmunol.1900284. [PMID: 32482710]
  • Chu-Wen Li, Min-Zhen Deng, Zhi-Jie Gao, Yuan-Ye Dang, Guo-Dong Zheng, Xiu-Juan Yang, Ying-Xin Chao, Ye-Feng Cai, Xiao-Li Wu. Effects of compound K, a metabolite of ginsenosides, on memory and cognitive dysfunction in db/db mice involve the inhibition of ER stress and the NLRP3 inflammasome pathway. Food & function. 2020 May; 11(5):4416-4427. doi: 10.1039/c9fo02602a. [PMID: 32374299]
  • Md Shahiduzzaman, Refaat Ras, Giovanni Widmer. Effect of Ginsenoside-Rh2 and Curcurbitacin-B on Cryptosporidium parvum in vitro. Experimental parasitology. 2020 May; 212(?):107873. doi: 10.1016/j.exppara.2020.107873. [PMID: 32165146]
  • Chunmei Li, Zhezhe Wang, Tong Wang, Guangfei Wang, Guisheng Li, Chengfeng Sun, Jian Lin, Liqin Sun, Xilin Sun, Susan Cho, Hongbo Wang, Yonglin Gao, Jingwei Tian. Repeated-dose 26-week oral toxicity study of ginsenoside compound K in Beagle dogs. Journal of ethnopharmacology. 2020 Feb; 248(?):112323. doi: 10.1016/j.jep.2019.112323. [PMID: 31639487]
  • Dong Yang, Xin Li, Xiaoyan Zhang. Ginsenoside Rh2 induces DNA damage and autophagy in vestibular schwannoma is dependent of LAMP2 transcriptional suppression. Biochemical and biophysical research communications. 2020 02; 522(2):300-307. doi: 10.1016/j.bbrc.2019.11.026. [PMID: 31771882]
  • Ji-Hyeon Jeon, Sowon Lee, Wonpyo Lee, Sojeong Jin, Mihwa Kwon, Chul Hwi Shin, Min-Koo Choi, Im-Sook Song. Herb-Drug Interaction of Red Ginseng Extract and Ginsenoside Rc with Valsartan in Rats. Molecules (Basel, Switzerland). 2020 Jan; 25(3):. doi: 10.3390/molecules25030622. [PMID: 32023909]
  • Yuanyuan Yang, Xiaojian Liu, Shuang Li, Yanhao Chen, Yongxu Zhao, Yuda Wei, Yan Qiu, Yan Liu, Zhihua Zhou, Jun Han, Guohao Wu, Qiurong Ding. Genome-scale CRISPR screening for potential targets of ginsenoside compound K. Cell death & disease. 2020 01; 11(1):39. doi: 10.1038/s41419-020-2234-5. [PMID: 31959745]
  • Luping Zhou, Lulu Chen, Xiangchang Zeng, Jianwei Liao, Dongsheng Ouyang. Ginsenoside compound K alleviates sodium valproate-induced hepatotoxicity in rats via antioxidant effect, regulation of peroxisome pathway and iron homeostasis. Toxicology and applied pharmacology. 2020 01; 386(?):114829. doi: 10.1016/j.taap.2019.114829. [PMID: 31734319]
  • Wan-Han Hsu, Kuo-Feng Hua, Li-Heng Tuan, Yu-Ling Tsai, Lichieh Julie Chu, Yu-Chieh Lee, Wei-Ting Wong, Sheau-Long Lee, Jenn-Haung Lai, Ching-Liang Chu, Ling-Jun Ho, Hsiao-Wen Chiu, Yu-Juei Hsu, Cheng-Hsu Chen, Shuk-Man Ka, Ann Chen. Compound K inhibits priming and mitochondria-associated activating signals of NLRP3 inflammasome in renal tubulointerstitial lesions. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2020 01; 35(1):74-85. doi: 10.1093/ndt/gfz073. [PMID: 31065699]
  • Xin Jin, Qing Yang, Ning Cai, Zhenhai Zhang. A cocktail of betulinic acid, parthenolide, honokiol and ginsenoside Rh2 in liposome systems for lung cancer treatment. Nanomedicine (London, England). 2020 01; 15(1):41-54. doi: 10.2217/nnm-2018-0479. [PMID: 31868113]
  • Yingying Chen, Yuqiang Zhang, Wei Song, Ying Zhang, Xiu Dong, Mingqi Tan. Ginsenoside Rh2 Improves the Cisplatin Anti-tumor Effect in Lung Adenocarcinoma A549 Cells via Superoxide and PD-L1. Anti-cancer agents in medicinal chemistry. 2020; 20(4):495-503. doi: 10.2174/1871520619666191209091230. [PMID: 31814556]
  • Hadi Zare-Zardini, Ashraf Alemi, Asghar Taheri-Kafrani, Seyed Ahmad Hosseini, Hossein Soltaninejad, Amir Ali Hamidieh, Mojtaba Haghi Karamallah, Majid Farrokhifar, Mohammad Farrokhifar. Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study. Drug design, development and therapy. 2020; 14(?):3315-3324. doi: 10.2147/dddt.s261027. [PMID: 32884236]
  • Stefan Bidula, Kshitija Dhuna, Ray Helliwell, Leanne Stokes. Positive allosteric modulation of P2X7 promotes apoptotic cell death over lytic cell death responses in macrophages. Cell death & disease. 2019 11; 10(12):882. doi: 10.1038/s41419-019-2110-3. [PMID: 31767863]
  • Qifang Liu, Lidan Liu, Hongmei Liu, Jingjing Jiang, Shanbin Guo, Cong Wang, Yi Jia, Yue Tian. Compound K attenuated hepatectomy-induced post-operative cognitive dysfunction in aged mice via LXRα activation. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2019 Nov; 119(?):109400. doi: 10.1016/j.biopha.2019.109400. [PMID: 31514067]
  • Tiantian Xie, Zhigang Li, Bo Li, Rongrong Sun, Peiying Zhang, Junxiu Lv. Characterization of ginsenoside compound K metabolites in rat urine and feces by ultra-performance liquid chromatography with electrospray ionization quadrupole time-of-flight tandem mass spectrometry. Biomedical chromatography : BMC. 2019 Nov; 33(11):e4643. doi: 10.1002/bmc.4643. [PMID: 31271658]
  • Yonglin Gao, Tong Wang, Guangfei Wang, Guisheng Li, Chengfeng Sun, Zhumao Jiang, Jianrong Yang, Yanshen Li, Yanli You, Xuran Wu, Liqin Sun, Hongbo Wang, Chunmei Li, Jingwei Tian, Jing Zhu, Kezhou Wang, Susan Cho. Preclinical safety of ginsenoside compound K: Acute, and 26-week oral toxicity studies in mice and rats. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. 2019 Sep; 131(?):110578. doi: 10.1016/j.fct.2019.110578. [PMID: 31201900]
  • Chang-Hao Cui, Byeong-Min Jeon, Yaoyao Fu, Wan-Taek Im, Sun-Chang Kim. High-density immobilization of a ginsenoside-transforming β-glucosidase for enhanced food-grade production of minor ginsenosides. Applied microbiology and biotechnology. 2019 Sep; 103(17):7003-7015. doi: 10.1007/s00253-019-09951-4. [PMID: 31289903]
  • Huayu Yan, Huding Jin, Yu Fu, Zhenxing Yin, Chengri Yin. Production of Rare Ginsenosides Rg3 and Rh2 by Endophytic Bacteria from Panax ginseng. Journal of agricultural and food chemistry. 2019 Aug; 67(31):8493-8499. doi: 10.1021/acs.jafc.9b03159. [PMID: 31310523]
  • Mei Zhang, Shanshan Hu, Juan Tao, Weijie Zhou, Rui Wang, Yu Tai, Feng Xiao, Qingtong Wang, Wei Wei. Ginsenoside compound-K inhibits the activity of B cells through inducing IgD-B cell receptor endocytosis in mice with collagen-induced arthritis. Inflammopharmacology. 2019 Aug; 27(4):845-856. doi: 10.1007/s10787-019-00608-2. [PMID: 31165333]
  • Yi Zheng, Zhizhong Zheng, Yanlin Ming, Yazhu Bai, Lianghua Chen, Wen Huang, Mengshi Lin, Shaosong Liu, Jianbo Xiao, Hetong Lin. Compound K producing from the enzymatic conversion of gypenoside by naringinase. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. 2019 Aug; 130(?):253-261. doi: 10.1016/j.fct.2019.05.027. [PMID: 31103740]
  • Zeng Qi, Wei Li, Jing Tan, Cuizhu Wang, Hongqiang Lin, Baisong Zhou, Jinping Liu, Pingya Li. Effect of ginsenoside Rh2 on renal apoptosis in cisplatin-induced nephrotoxicity in vivo. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2019 Aug; 61(?):152862. doi: 10.1016/j.phymed.2019.152862. [PMID: 31048124]
  • Erica Bessell, Nicholas R Fuller, Tania P Markovic, Jessica Burk, Tegan Picone, Chelsea Hendy, Michelle M C Tan, Ian D Caterson. Effects of alpha-cyclodextrin on cholesterol control and Compound K on glycaemic control in people with pre-diabetes: Protocol for a Phase III randomized controlled trial. Clinical obesity. 2019 Aug; 9(4):e12324. doi: 10.1111/cob.12324. [PMID: 31172667]
  • Sandrine L Verstraeten, Magali Deleu, Maria Janikowska-Sagan, Emily J S Claereboudt, Laurence Lins, Donatienne Tyteca, Marie-Paule Mingeot-Leclercq. The activity of the saponin ginsenoside Rh2 is enhanced by the interaction with membrane sphingomyelin but depressed by cholesterol. Scientific reports. 2019 05; 9(1):7285. doi: 10.1038/s41598-019-43674-w. [PMID: 31086211]
  • Zhihua Wang, Unchol Kim, Yanting Jiao, Chaowen Li, Yingying Guo, Xiaoyao Ma, Min Jiang, Zhihong Jiang, Yuanyuan Hou, Gang Bai. Quantitative Proteomics Combined with Affinity MS Revealed the Molecular Mechanism of Ginsenoside Antitumor Effects. Journal of proteome research. 2019 05; 18(5):2100-2108. doi: 10.1021/acs.jproteome.8b00972. [PMID: 30860844]
  • Yin-Ping Guo, Man-Yun Chen, Li Shao, Wei Zhang, Tai Rao, Hong-Hao Zhou, Wei-Hua Huang. Quantification of Panax notoginseng saponins metabolites in rat plasma with in vivo gut microbiota-mediated biotransformation by HPLC-MS/MS. Chinese journal of natural medicines. 2019 Mar; 17(3):231-240. doi: 10.1016/s1875-5364(19)30026-3. [PMID: 30910060]
  • Li-Xue Chen, Zeng Qi, Zi-Jun Shao, Shan-Shan Li, Yu-Li Qi, Kun Gao, Song-Xin Liu, Zhuo Li, Yin-Shi Sun, Ping-Ya Li. Study on Antidepressant Activity of Pseudo-Ginsenoside HQ on Depression-Like Behavior in Mice. Molecules (Basel, Switzerland). 2019 Mar; 24(5):. doi: 10.3390/molecules24050870. [PMID: 30823679]
  • Hiroyuki Fukami, Taro Ueda, Nobuya Matsuoka. Pharmacokinetic Study of Compound K in Japanese Subjects After Ingestion of Panax ginseng Fermented by Lactobacillus paracasei A221 Reveals Significant Increase of Absorption into Blood. Journal of medicinal food. 2019 Mar; 22(3):257-263. doi: 10.1089/jmf.2018.4271. [PMID: 30543483]
  • Li Yang, Chun-Yang Wang, Xiao-Nv Xie, Yi-Cheng Wang, Jing-Bo Peng, Wei-Hua Huang, Yao Chen, Dong-Sheng Ouyang, Zhi-Rong Tan. LC-MS/MS determination of ginsenoside compound K and its metabolite 20 (S)-protopanaxadiol in human plasma and urine: applications in a clinical study. Bioanalysis. 2019 Mar; 11(5):365-380. doi: 10.4155/bio-2018-0185. [PMID: 30873858]
  • Zeng Qi, Lixue Chen, Zhuo Li, Zijun Shao, Yuli Qi, Kun Gao, Songxin Liu, Yinshi Sun, Pingya Li, Jinping Liu. Immunomodulatory Effects of (24R)-Pseudo-Ginsenoside HQ and (24S)-Pseudo-Ginsenoside HQ on Cyclophosphamide-Induced Immunosuppression and Their Anti-Tumor Effects Study. International journal of molecular sciences. 2019 Feb; 20(4):. doi: 10.3390/ijms20040836. [PMID: 30769948]
  • Yingying Chen, Yuqiang Zhang, Wei Song, Ying Zhang, Xiu Dong, Mingqi Tan. Ginsenoside Rh2 Inhibits Migration of Lung Cancer Cells under Hypoxia via mir-491. Anti-cancer agents in medicinal chemistry. 2019; 19(13):1633-1641. doi: 10.2174/1871520619666190704165205. [PMID: 31272362]
  • Chong-Zhi Wang, Haiqiang Yao, Chun-Feng Zhang, Lina Chen, Jin-Yi Wan, Wei-Hua Huang, Jinxiang Zeng, Qi-Hui Zhang, Zhi Liu, Jinbin Yuan, Yi Bi, Clara Sava-Segal, Wei Du, Ming Xu, Chun-Su Yuan. American ginseng microbial metabolites attenuate DSS-induced colitis and abdominal pain. International immunopharmacology. 2018 Nov; 64(?):246-251. doi: 10.1016/j.intimp.2018.09.005. [PMID: 30212750]
  • Delgerzul Baatar, Muhammad Zubair Siddiqi, Wan Taek Im, Nisar Ul Khaliq, Seong Gu Hwang. Anti-Inflammatory Effect of Ginsenoside Rh2-Mix on Lipopolysaccharide-Stimulated RAW 264.7 Murine Macrophage Cells. Journal of medicinal food. 2018 Oct; 21(10):951-960. doi: 10.1089/jmf.2018.4180. [PMID: 30239266]
  • Cong Lu, Yan Wang, Jingwei Lv, Ning Jiang, Bei Fan, Lina Qu, Yinghui Li, Shanguang Chen, Fengzhong Wang, Xinmin Liu. Ginsenoside Rh2 reverses sleep deprivation-induced cognitive deficit in mice. Behavioural brain research. 2018 09; 349(?):109-115. doi: 10.1016/j.bbr.2018.03.005. [PMID: 29544964]
  • Ni Li, Zhican Lin, Wei Chen, Yi Zheng, Yanlin Ming, Zhizhong Zheng, Wen Huang, Lianghua Chen, Jianbo Xiao, Hetong Lin. Corilagin from longan seed: Identification, quantification, and synergistic cytotoxicity on SKOv3ip and hey cells with ginsenoside Rh2 and 5-fluorouracil. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. 2018 Sep; 119(?):133-140. doi: 10.1016/j.fct.2018.05.018. [PMID: 29751073]
  • Sandrine L Verstraeten, Marie Albert, Adrien Paquot, Giulio G Muccioli, Donatienne Tyteca, Marie-Paule Mingeot-Leclercq. Membrane cholesterol delays cellular apoptosis induced by ginsenoside Rh2, a steroid saponin. Toxicology and applied pharmacology. 2018 08; 352(?):59-67. doi: 10.1016/j.taap.2018.05.014. [PMID: 29782965]
  • Honglin Li, Nan Huang, Weikang Zhu, Jianchun Wu, Xiaohui Yang, Wenjing Teng, Jianhui Tian, Zhihong Fang, Yingbin Luo, Min Chen, Yan Li. Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2. BMC cancer. 2018 May; 18(1):579. doi: 10.1186/s12885-018-4299-4. [PMID: 29783929]
  • Xiu-Wei Yang, Li-Yuan Ma, Qi-Le Zhou, Wei Xu, You-Bo Zhang. SIRT1 activator isolated from artificial gastric juice incubate of total saponins in stems and leaves of Panax ginseng. Bioorganic & medicinal chemistry letters. 2018 02; 28(3):240-243. doi: 10.1016/j.bmcl.2017.12.067. [PMID: 29317167]
  • Zhao-Hui Jin, Wen Qiu, Hui Liu, Xue-Hua Jiang, Ling Wang. Enhancement of oral bioavailability and immune response of Ginsenoside Rh2 by co-administration with piperine. Chinese journal of natural medicines. 2018 Feb; 16(2):143-149. doi: 10.1016/s1875-5364(18)30041-4. [PMID: 29455730]
  • Xiangyan Li, Qingxia Huang, Manying Wang, Xiuci Yan, Xinying Song, Rui Ma, Rui Jiang, Daqing Zhao, Liwei Sun. Compound K Inhibits Autophagy-Mediated Apoptosis Through Activation of the PI3K-Akt Signaling Pathway Thus Protecting Against Ischemia/Reperfusion Injury. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology. 2018; 47(6):2589-2601. doi: 10.1159/000491655. [PMID: 29996122]
  • Qi Li, Bai Li, Chengya Dong, Yajie Wang, Qi Li. 20(S)-Ginsenoside Rh2 suppresses proliferation and migration of hepatocellular carcinoma cells by targeting EZH2 to regulate CDKN2A-2B gene cluster transcription. European journal of pharmacology. 2017 Nov; 815(?):173-180. doi: 10.1016/j.ejphar.2017.09.023. [PMID: 28928088]
  • Peng Li, XiaoYue Zhou, Ding Qu, Mengfei Guo, Chenyi Fan, Tong Zhou, Yang Ling. Preliminary study on fabrication, characterization and synergistic anti-lung cancer effects of self-assembled micelles of covalently conjugated celastrol-polyethylene glycol-ginsenoside Rh2. Drug delivery. 2017 Nov; 24(1):834-845. doi: 10.1080/10717544.2017.1326540. [PMID: 28532223]
  • Joon-Seung Han, Jong Hwan Sung, Seung Kwon Lee. Inhibition of Cholesterol Synthesis in HepG2 Cells by GINST-Decreasing HMG-CoA Reductase Expression Via AMP-Activated Protein Kinase. Journal of food science. 2017 Nov; 82(11):2700-2705. doi: 10.1111/1750-3841.13828. [PMID: 29065216]
  • Feifei Yang, Jing Zhou, Xiao Hu, Stephanie Kyoungchun Yu, Chunyu Liu, Ruile Pan, Qi Chang, Xinmin Liu, Yonghong Liao. Preparation and evaluation of self-microemulsions for improved bioavailability of ginsenoside-Rh1 and Rh2. Drug delivery and translational research. 2017 10; 7(5):731-737. doi: 10.1007/s13346-017-0402-7. [PMID: 28677033]